UK-headquartered Fishawack Group has acquired Swiss medical communications agency Archimed.
Based in Zofingen, Switzerland, Archimed offers clients medical writing, project management, and clinical research, consultancy and pharmacovigilance services.
The deal strengthens Fishawack’s presence in Switzerland, adding to the group’s Basel-based medical communications agency Phocus.
“We are very excited to have Archimed join the Group,” said Oliver Dennis, Fishawack CEO.
“In April, we linked up with a new investor, Growth Capital Partners, to allow us to continue to build the Fishawack Group, and this acquisition is the first step in our new phase of growth. We now have a global team of over 150 staff and the largest medical communications capability in Switzerland of any agency organisation.”
Commenting on the acquisition, Françoise Rampelberg, general manager of Archimed, said: “I am very pleased that Archimed is becoming part of a larger group.
“There will be many opportunities for synergies across the group moving forward, and Fishawack and Archimed have very similar philosophies about quality, flexibility and client satisfaction.
“Our clients will benefit from access to further high-quality resources. Being part of a larger group will also offer more opportunities for the Archimed team.”